At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead. As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease. To learn more please visit www.hookipapharma.com.
View Top Employees from HOOKIPA Pharma Inc.Website | https://www.hookipapharma.com/ |
Ticker | HOOK |
Revenue | $14.6 million |
Employees | 132 (128 on RocketReach) |
Founded | 2011 |
Address | 350 5th Ave Ste 7240, New York City, New York 10118, US |
Phone | (917) 238-0980 |
Fax | (431) 890-6360 |
Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Vaccines, Healthcare, Science and Engineering, Drug Discovery, Infectious diseases, Clinical Trials, Immuno-Oncology, Health Care, Therapeutics |
Web Rank | 13 Million |
Keywords | Biopharmaceuticals, Cancer Treatment, Prostate Cancer Treatment, Liver Disease |
Competitors | Altimmune, Inc., Celldex Therapeutics, MacroGenics, Inc., NexImmune, Inc., Selecta Biosciences |
SIC | SIC Code 87 Companies, SIC Code 8734 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54138 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5413 Companies |
Looking for a particular HOOKIPA Pharma Inc. employee's phone or email?
The HOOKIPA Pharma Inc. annual revenue was $14.6 million in 2024.
Christine Baker is the COO of HOOKIPA Pharma Inc..
128 people are employed at HOOKIPA Pharma Inc..
HOOKIPA Pharma Inc. is based in New York City, New York.
The NAICS codes for HOOKIPA Pharma Inc. are [54138, 541, 54, 5413].
The SIC codes for HOOKIPA Pharma Inc. are [87, 8734, 873].